Publication | Open Access
A novel prognostic model for osteosarcoma using circulating <scp>CXCL</scp>10 and <scp>FLT</scp>3<scp>LG</scp>
30
Citations
36
References
2016
Year
High circulating levels of CXCL10 and FLT3LG predicted worse survival for patients with OS. Because both CXCL10 and FL3LG axes are potentially targetable, further study may lead to novel risk-based stratification and therapy for OS. Cancer 2017;144-154. © 2016 American Cancer Society.
| Year | Citations | |
|---|---|---|
Page 1
Page 1